NEUWAY® Pharma

NEUWAY Pharma is committed to bringing transformative neuropharmaceuticals across the blood-brain barrier through its proprietary, virus-free EnPC® protein particle technology.

The company aims to be a partner of choice in particular for antibody and mRNA drug developers stymied by the hurdles of delivering these and other drug modalities into the brain and CNS tissue.

Operating as a drug developer and a delivery expert, NEUWAY will demonstrate the value of its technology through its internal orphan neurological disease pipeline and partnered programs.